Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study.

Autor: Suzuki, Hiroyoshi, Shin, Toshitaka, Fukasawa, Satoshi, Hashine, Katsuyoshi, Kitani, Sumiko, Ohtake, Noriyuki, Shibayama, Kazuhiro, Tran, Namphuong, Mundle, Suneel, Fizazi, Karim, Matsubara, Nobuaki
Zdroj: Japanese Journal of Clinical Oncology; Jul2020, Vol. 50 Issue 7, p810-820, 11p
Databáze: Complementary Index